These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

563 related articles for article (PubMed ID: 8119492)

  • 1. Bacterial endotoxin: molecular relationships of structure to activity and function.
    Rietschel ET; Kirikae T; Schade FU; Mamat U; Schmidt G; Loppnow H; Ulmer AJ; Zähringer U; Seydel U; Di Padova F
    FASEB J; 1994 Feb; 8(2):217-25. PubMed ID: 8119492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case for an endotoxic conformation.
    Seydel U; Brandenburg K; Rietschel ET
    Prog Clin Biol Res; 1994; 388():17-30. PubMed ID: 7831357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The chemical structure of bacterial endotoxin in relation to bioactivity.
    Rietschel ET; Kirikae T; Schade FU; Ulmer AJ; Holst O; Brade H; Schmidt G; Mamat U; Grimmecke HD; Kusumoto S
    Immunobiology; 1993 Apr; 187(3-5):169-90. PubMed ID: 8330896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bacterial endotoxins: relationship between chemical structure and biological effect].
    Rietschel ET; Brade L; Schade FU; Seydel U; Zähringer U; Mamat U; Schmidt G; Ulmer AJ; Loppnow H; Flad HD
    Immun Infekt; 1993 Apr; 21(2):26-35. PubMed ID: 8340135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dual role of lipopolysaccharide as effector and target molecule.
    Wiese A; Brandenburg K; Ulmer AJ; Seydel U; Müller-Loennies S
    Biol Chem; 1999; 380(7-8):767-84. PubMed ID: 10494826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of endotoxin-induced monokine release in human monocytes by lipid A partial structures that inhibit binding of 125I-lipopolysaccharide.
    Ulmer AJ; Feist W; Heine H; Kirikae T; Kirikae F; Kusumoto S; Kusama T; Brade H; Schade U; Rietschel ET
    Infect Immun; 1992 Dec; 60(12):5145-52. PubMed ID: 1280625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial lipopolysaccharides: structure, metabolism and mechanisms of action.
    Freudenberg MA; Galanos C
    Int Rev Immunol; 1990; 6(4):207-21. PubMed ID: 2102904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes.
    Golenbock DT; Hampton RY; Qureshi N; Takayama K; Raetz CR
    J Biol Chem; 1991 Oct; 266(29):19490-8. PubMed ID: 1918061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newer aspects of the chemical structure and biological activity of bacterial endotoxins.
    Rietschel ET; Brade H; Brade L; Kaca W; Kawahara K; Lindner B; Lüderitz T; Tomita T; Schade U; Seydel U
    Prog Clin Biol Res; 1985; 189():31-51. PubMed ID: 2413465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of endotoxin or lipid A-induced tumor necrosis factor production by synthetic lipid A partial structures in human peripheral blood mononuclear cells.
    Wang MH; Flad HD; Feist W; Musehold J; Kusumoto S; Brade H; Gerdes J; Rietschel HT; Ulmer AJ
    Lymphokine Cytokine Res; 1992 Feb; 11(1):23-31. PubMed ID: 1576244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial lipopolysaccharides and innate immunity.
    Alexander C; Rietschel ET
    J Endotoxin Res; 2001; 7(3):167-202. PubMed ID: 11581570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-endotoxin monoclonal antibodies inhibit secretion of tumor necrosis factor-alpha by two distinct mechanisms.
    Burd RS; Battafarano RJ; Cody CS; Farber MS; Ratz CA; Dunn DL
    Ann Surg; 1993 Sep; 218(3):250-9; discussion 259-61. PubMed ID: 8373268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist.
    Mullarkey M; Rose JR; Bristol J; Kawata T; Kimura A; Kobayashi S; Przetak M; Chow J; Gusovsky F; Christ WJ; Rossignol DP
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1093-102. PubMed ID: 12604686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological activities of lipopolysaccharides are determined by the shape of their lipid A portion.
    Schromm AB; Brandenburg K; Loppnow H; Moran AP; Koch MH; Rietschel ET; Seydel U
    Eur J Biochem; 2000 Apr; 267(7):2008-13. PubMed ID: 10727940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma lipopolysaccharide (LPS)-binding protein. A key component in macrophage recognition of gram-negative LPS.
    Mathison JC; Tobias PS; Wolfson E; Ulevitch RJ
    J Immunol; 1992 Jul; 149(1):200-6. PubMed ID: 1607653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of tumor necrosis factor-alpha release by lipopolysaccharide and defined lipopolysaccharide partial structures.
    Feist W; Ulmer AJ; Musehold J; Brade H; Kusumoto S; Flad HD
    Immunobiology; 1989 Oct; 179(4-5):293-307. PubMed ID: 2613271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diversity of the core oligosaccharide in lipopolysaccharides.
    Silipo A; Molinaro A
    Subcell Biochem; 2010; 53():69-99. PubMed ID: 20593263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redefining the requisite lipopolysaccharide structure in Escherichia coli.
    Meredith TC; Aggarwal P; Mamat U; Lindner B; Woodard RW
    ACS Chem Biol; 2006 Feb; 1(1):33-42. PubMed ID: 17163638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic anti-endotoxin peptides inhibit cytoplasmic LPS-mediated responses.
    Pfalzgraff A; Heinbockel L; Su Q; Brandenburg K; Weindl G
    Biochem Pharmacol; 2017 Sep; 140():64-72. PubMed ID: 28539262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipopolysaccharide (LPS)-reactive monoclonal antibodies fail to inhibit LPS-induced tumor necrosis factor secretion by mouse-derived macrophages.
    Chia JK; Pollack M; Guelde G; Koles NL; Miller M; Evans ME
    J Infect Dis; 1989 May; 159(5):872-80. PubMed ID: 2651532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.